Journal of Nuclear Medicine

SEP 24, 2026 · JOURNAL ARTICLE

Renal Function Decline After 177 Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score Analysis

Journal of Nuclear Medicine

We conducted a study to determine the effects of 177Lu-PSMA-617 treatment on renal function decline in patients with metastatic castration-resistant prostate cancer (mCRPC) shortly

SEP 24, 2026 · JOURNAL ARTICLE

Recombinant Human Thyrotropin Versus Thyroid Hormone Withdrawal for Radioactive Iodine Therapy in Metastatic Differentiated Thyroid Cancer: A Multicenter Retrospective Study

Journal of Nuclear Medicine

This study compared clinical and safety outcomes of radioactive iodine therapies administered after thyroid hormone withdrawal (THW) versus recombinant human thyrotropin (rhTSH) in